Tagged With cancer treatment

Even under the best of circumstances, cancer treatment can be an excruciating, costly ordeal that tragically doesn't even work sometimes. In light of that reality, scientists and doctors have long searched for a way to proactively head off the problem using a vaccine. One potential approach to a cancer vaccine, highlighted in a new study published today in Cell Stem Cell, might involve using our own reprogrammed stem cells to better train the immune system against several - and maybe even all - types of cancers.

One of the worst side-effects of chemotherapy treatment is the inadvertent damage it causes to the gastrointestinal (GI) system, leading to nausea, vomiting and diarrhoea. While there are short-term treatments available to help deal with these symptoms, oftentimes the damage can lead to chronic GI problems. Now, researchers at the University of Pittsburgh say they have found a way to short circuit the molecular pathway that sparks this gut damage in the first place.

Predicting the future is near impossible -- but that doesn‘t stop us all from having a red hot go. Human beings have been predicting the future since the beginning of history and the results range from the hilarious to the downright uncanny.

One thing all future predictions have in common: they‘re rooted in our current understanding of how the world works. It‘s difficult to escape that mindset. We have no idea how technology will evolve, so our ideas are connected to the technology of today.

You have, as of today, a one hundred per cent chance of dying. But a lot of people would like a little more time to do things, like eat interestingly-shaped pastas, or play catch with their grandchildren. That makes sense. I'd also like to do those things. But sometimes, our pursuit to eat lots of pasta or die trying leads some of us to make decisions that don't actually help -- like taking alternative, instead of conventional, cancer treatments.

Developed by a team of international and Australian scientists, venetoclax has just received Australian approval. The anti-cancer drug has the power to "melt away" certain advanced forms of chronic lymphocytic leukaemia (CLL) - the most common type of leukaemia in Australia, with 1300 people diagnosed each year.